Caxton Associates (New York)’s Teradyne TER Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
– Sell
-57,742
Closed -$8.56M – 646
2024
Q2
$8.56M Buy
+57,742
New +$7.33M 0.29% 40
2024
Q1
– Sell
-14,371
Closed -$1.56M – 580
2023
Q4
$1.56M Buy
+14,371
New +$1.36M 0.08% 157
2023
Q1
– Sell
-8,264
Closed -$722K – 631
2022
Q4
$722K Sell
8,264
-9,562
-54% -$819K 0.05% 177
2022
Q3
$1.34M Buy
17,826
+14,116
+380% +$1.29M 0.18% 66
2022
Q2
$332K Buy
3,710
+212
+6% +$22.1K 0.03% 353
2022
Q1
$414K Buy
+3,498
New +$443K 0.03% 292
2020
Q4
– Sell
-4,021
Closed -$320K – 309
2020
Q3
$320K Buy
+4,021
New +$341K 0.03% 186
2018
Q1
– Sell
-175,000
Closed -$7.33M – 429
2017
Q4
$7.33M Buy
175,000
+163,000
+1,358% +$6.72M 0.36% 75
2017
Q3
$447K Sell
12,000
-2,800
-19% -$97K 0.02% 376
2017
Q2
$444K Buy
+14,800
New +$498K 0.02% 379

Other funds holding TER

Caxton Associates (New York)'s TER Position: Q3 2024 in Review

Caxton Associates (New York) sold out of Teradyne (TER) in Q3 2024, closing a stake of 57,742 shares — an estimated $8.56M sold.

Caxton Associates (New York) first reported a position in TER in Q2 2017 and held it in 10 quarters. The position peaked at $8.56M in Q2 2024. 755 funds tracked by Wall St. Rank hold TER as of Q3 2024.

  • Caxton Associates (New York) reported no remaining Teradyne position as of Q3 2024 after selling out during the quarter.
  • Caxton Associates (New York) sold 57,742 Teradyne shares in Q3 2024, an estimated $8.56M.
  • Caxton Associates (New York) first reported a position in Teradyne in Q2 2017 and held it in 10 quarters.
  • Caxton Associates (New York)'s Teradyne position peaked at $8.56M in Q2 2024.
  • 755 funds tracked by Wall St. Rank held Teradyne as of Q3 2024.

Based on Caxton Associates (New York)'s 13F filing for Q3 2024, filed 14 Nov 2024.